Cargando…

Correction to: Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial

Detalles Bibliográficos
Autores principales:	Lee, Hyuk, Kim, Beom Jin, Kim, Sang Gyun, Kim, Jin Il, Choi, Il Ju, Lee, Yong Chan, Kim, Jae G., Kim, Jae J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732532/ https://www.ncbi.nlm.nih.gov/pubmed/29246171 http://dx.doi.org/10.1186/s13063-017-2393-6

Ejemplares similares

Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial
por: Lee, Hyuk, et al.
Publicado: (2017)

Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea
por: Kim, Beom Jin, et al.
Publicado: (2019)

Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy of Helicobacter pylori Eradication
por: Jung, Sung Min, et al.
Publicado: (2016)

The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea
por: Chung, Kwang Hyun, et al.
Publicado: (2014)

Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial
por: Kim, Joon Sung, et al.
Publicado: (2016)

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial
por: Kim, Young-Il, et al.
Publicado: (2021)

Clarithromycin-Based Standard Triple Therapy Can Still Be Effective for Helicobacter pylori Eradication in Some Parts of the Korea
por: Yoon, Kyu-Hyun, et al.
Publicado: (2014)

Effect of Helicobacter pylori Treatment on Long-term Mortality in Patients with Hypertension
por: Kim, Young-Il, et al.
Publicado: (2020)

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
por: Chang, Ji Young, et al.
Publicado: (2017)

Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?
por: Gong, Eun Jeong, et al.
Publicado: (2014)

Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of Helicobacter pylori: A Real-World Evidence Study
por: Jung, Yoon Suk, et al.
Publicado: (2023)

Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis
por: Kim, Joon Sung, et al.
Publicado: (2013)

Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis
por: Kim, Beom Jin, et al.
Publicado: (2016)

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
por: Lim, Joo Hyun, et al.
Publicado: (2017)

Efficacy of Twice a Day Bismuth Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection
por: Kim, Jeemyoung, et al.
Publicado: (2022)

Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Helicobacter pylori Eradication
por: Park, Chan Hyuk, et al.
Publicado: (2022)

Effect of Helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes
por: Kim, Young-Il, et al.
Publicado: (2021)

Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success
por: Kim, Beom Jin, et al.
Publicado: (2019)

Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020
por: Jung, Hye-Kyung, et al.
Publicado: (2021)

Developing Operational Definitions Related to Helicobacter pylori Eradication Therapy
por: Park, Chan Hyuk, et al.
Publicado: (2023)

Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial
por: Yoon, Hyuk, et al.
Publicado: (2016)

Seven‐day vonoprazan‐based triple therapy as first‐line Helicobacter pylori treatment in comparison with extended sequential therapy
por: Chiu, Yu‐Tse, et al.
Publicado: (2023)

Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea
por: Moon, Ji Yoon, et al.
Publicado: (2013)

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
por: Lee, Seung Woo, et al.
Publicado: (2020)

Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication
por: Kwon, Yong Hwan, et al.
Publicado: (2023)

Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial
por: Choi, Yoon Jin, et al.
Publicado: (2022)

Treatment of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis
por: Lee, Sang Wook, et al.
Publicado: (2015)

Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening to Helicobacter pylori Eradication in Korea
por: Kim, Young-Il, et al.
Publicado: (2022)

Does Standard Triple Therapy Still Have a Role in First-Line Helicobacter pylori Eradication in Korea?
por: Jeon, Hye Kyung, et al.
Publicado: (2014)

Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
por: Lee, Seong tae, et al.
Publicado: (2015)

The Prevalence of Multidrug Resistance of Helicobacter pylori and Its Impact on Eradication in Korea from 2017 to 2019: A Single-Center Study
por: Park, Jae Yong, et al.
Publicado: (2020)

Helicobacter pylori and Molecular Markers as Prognostic Indicators for Gastric Cancer in Korea
por: Kim, Hee Jin, et al.
Publicado: (2014)

Long-Term Recurrence Rates of Peptic Ulcers without Helicobacter pylori
por: Seo, Jae Hyun, et al.
Publicado: (2016)

Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Helicobacter pylori Infection
por: Jung, Jae Hyun, et al.
Publicado: (2018)

Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation
por: Lee, Jung Wook, et al.
Publicado: (2021)

“Concomitant” or “sequential” eradication of Helicobacter pylori: which regimen comes first?
por: Georgopoulos, Sotirios D.
Publicado: (2014)

Substitutions in Penicillin-Binding Protein 1 in Amoxicillin-Resistant Helicobacter pylori Strains Isolated from Korean Patients
por: Kim, Beom Jin, et al.
Publicado: (2013)

Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
por: Kim, Sung Eun, et al.
Publicado: (2015)

Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy
por: Chang, Young Woon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n7d74s0am5nev26tucbmput2sh